Griffon Pharmaceuticals International SA
ActiveLimited or Corporation721001 - Research and experimental development in the pharmaceutical industrygriffonpharma.com
Biotechnology and Pharmaceuticals
Griffon Pharmaceuticals International SA is a Swiss AG registered in Epalinges, VD. Its registered activity falls under Research and experimental development in the pharmaceutical industry.
AI-enriched data· marks AI-enriched fields
AI Insight
Registry narrative generated from SHAB/SOGC facts.
Officers2Active Relations2Deleted Relations0SOGC Records1First Record25.01.2019Latest Activity30.01.2019
Registry Information
c/o address
- Swiss UID
- CHE-470.574.202
- Legal Name
- Griffon Pharmaceuticals International SA
- Legal Form
- Limited
- Incorporated
- 25 Jan 2019
- Share Capital
- 1'000 actions nominatives de CHF 100, avec restrictions quant à la transmissibilité selon statuts.
- Canton
- VD
- Status
- Active
- Country
- Switzerland
Company Purpose
Translating…
NOGA Codes
(Industry classification)Research and experimental development in the pharmaceutical industry
NPROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES72Scientific research and development721Research and experimental development on natural sciences and engineering7210Research and experimental development on natural sciences and engineering721001
Industry Health
Registered Address
Route de la Corniche 3, c/o Biopôle SA, Bâtiment SE-A, 1066 Epalinges
1066, Epalinges, VD
Companies at this address
Enrich from integrations
Pull data from your connected providers and merge it with the registry.
Registry Pulse
Registry pulse is a Pro feature
Current Directors & Officers
From the web
Sources (7)
Full List of Biotech Companies in Switzerland (2026)
pharmchoices.com
Griffon Pharmaceuticals International • Biopôle • Switzerland
biopole.ch
Griffon Pharmaceuticals International SA, Epalinges | OnlineInfo.ch Firmeninformation
onlineinfo.ch
Marc Cluzel: Postes, Relations & Réseau - Zonebourse
zonebourse.com
Pegylated bioactive peptides and uses thereof (US Patent 10918730)
exa.ai
Attending companies 2025 - Swiss Biotech Day
swissbiotechday.ch
NOTICE: CORRECTION TO NOTICE OF INTENT ISSUED JAN. 25, 2021 - VA Offer of Exclusive Patent License to Griffon Pharmaceuticals Inc. BY THE: Department of Veterans Affairs, Office of Research and Development (VA) ON: March 25, 2021 SUMMARY: As stated in the original notice of January 25, 2021, the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to grant to Griffon Pharmaceuticals, an exclusive license to U.S. Patent Application No. 16/611,147 and PCT/US2018/031261, associated with VA Invention Disclosure number 2016-145 titled, “Methods and Composition for Treating Liver Disease”. However, Griffon Pharmaceuticals’ corporate entity and address for this license agreement have changed to the following: Griffon Pharmaceuticals International SA, Route de la Corniche 3, Bâtiment SE-A, 1066 Épalinges, Switzerland. TECH NAME: “Methods and Composition for Treating Liver Disease” ACTION: CORRECTION TO NOTICE OF INTENT DATES: Comments must be received on or before April 14, 2021. ADDRESS: Send comments to Mr. Stefan Susta, Technology Transfer Specialist, Office of Research and Development (14RDTT), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, (937) 409-7993 (this is not a toll-free number), Email: stefan.susta@va.gov FOR FURTHER INFORMATION CONTACT: Send comments to Mr. Stefan Susta, Technology Transfer Specialist, Office of Research and Development (14RDTT), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, (937) 409-7993 (this is not a toll-free number), Email: stefan.susta@va.gov
federallabs.org